HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shoji Yamaoka Selected Research

Shoji Yamaoka Research Topics

Disease

12Neoplasms (Cancer)
01/2014 - 09/2003
7Infection
12/2015 - 11/2002
6T-Cell Leukemia (Leukemia, T Cell)
05/2011 - 08/2005
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2012 - 05/2004
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2012 - 03/2008
2Neoplasm Metastasis (Metastasis)
11/2011 - 05/2010
1Vesicular Stomatitis
12/2015
1Ovarian Neoplasms (Ovarian Cancer)
01/2014
1Colonic Neoplasms (Colon Cancer)
01/2014
1Leukemia
01/2014
1Melanoma (Melanoma, Malignant)
07/2013
1Porcine Reproductive and Respiratory Syndrome (PRRS)
07/2013
1Glioma (Gliomas)
07/2013
1Adenocarcinoma
07/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2010
1Lung Neoplasms (Lung Cancer)
12/2010
1Incontinentia Pigmenti (Bloch Sulzberger Syndrome)
08/2010
1Lymphoma (Lymphomas)
05/2010
1Breast Neoplasms (Breast Cancer)
12/2009
1Liver Diseases (Liver Disease)
12/2007
1Hodgkin Disease (Hodgkin's Disease)
01/2007
1Necrosis
07/2004
1Multiple Myeloma
07/2004
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
10/2003

Drug/Important Bio-Agent (IBA)

9NF-kappa B (NF-kB)IBA
05/2008 - 09/2003
6I-kappa B KinaseIBA
03/2008 - 10/2003
5Phosphotransferases (Kinase)IBA
01/2014 - 02/2005
3tax Gene Products (tax Gene Product)IBA
05/2011 - 12/2007
3Transcription Factors (Transcription Factor)IBA
02/2010 - 09/2005
2Proteasome Endopeptidase Complex (Proteasome)IBA
07/2013 - 07/2012
2N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA
01/2012 - 03/2008
1Glycoproteins (Glycoprotein)IBA
12/2015
1oregoninIBA
01/2014
1hirsutanoneIBA
01/2014
1Pattern Recognition ReceptorsIBA
07/2013
1Viral RNAIBA
07/2013
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2013
1Complementary DNA (cDNA)IBA
07/2013
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
07/2012
1QuercetinIBA
07/2012
1ATP dependent 26S protease (26S proteasome)IBA
07/2012
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2011
1Epstein-Barr virus EBV-associated membrane antigenIBA
11/2011
1cytidylyl-(3'-5')-cytidine (CpC)IBA
11/2011
1Nasopharyngeal carcinomaIBA
11/2011
1OsteopontinIBA
05/2011
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
08/2010
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
05/2010
1Guanylate KinaseIBA
05/2010
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
02/2010
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2009
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
01/2009
1InterferonsIBA
09/2008
1Interferon-alpha (Interferon Alfa)FDA Link
09/2008
1Neutralizing AntibodiesIBA
07/2008
1Viral Regulatory and Accessory ProteinsIBA
05/2008
1NF-kappa B kinaseIBA
05/2008
1DNA (Deoxyribonucleic Acid)IBA
05/2008
1AgarIBA
03/2008
1Carbon MonoxideIBA
12/2007
1NF-kappa B p52 SubunitIBA
01/2007
1delta proteinIBA
05/2006
1Interleukin-1 (Interleukin 1)IBA
07/2004
1LigandsIBA
07/2004
1Interleukin-6 (Interleukin 6)IBA
07/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2004
1Biological Tumor Markers (Tumor Markers)IBA
07/2004
1NF-kappaB inhibitor alphaIBA
10/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2003
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
09/2003
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
11/2002
1Transforming Growth Factor beta (TGF-beta)IBA
11/2002
1MucinsIBA
11/2002

Therapy/Procedure

1Heterologous Transplantation (Xenotransplantation)
01/2014
1Drug Therapy (Chemotherapy)
12/2010